Furosemide Tablets

DLA Troop Support · United States government procurement

Get new United States Pharmaceuticals tenders by email, free: Set up alerts

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$16.7M
Est. Value
December 07, 2026
Response Due
Active
Status

Want more tenders like this one?

We will email you a free list of open Pharmaceuticals tenders in the United States, usually within 10 minutes. No account needed.

Opportunity Overview

SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.

SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.

SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.

SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.

SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.

SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.

SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.

Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140

Contract Award for Furosemide Tablets SPE2D222D0140

Tenders like this are published on a national procurement portal that most bidders outside the United States never check.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Bidding on this? Book 15 minutes with us and we will pull the documents, past awards and a translation for this tender live with you. Book a walkthrough

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, cancel anytime.

Start a free GlobalGov account

Solicitation Details

Issuing agencyDLA Troop Support
CountryUnited States
CategoryPharmaceuticals
Estimated value$16.7M
NAICS325412 - Pharmaceutical Preparation Manufacturing
PSC6505
PublishedNovember 25, 2025
Procurement stageRequest for Proposal (RFP)
Response dueDecember 07, 2026
StatusOpen — accepting responses
Official sourceView original notice Track this tender · Get the tender pack: $49, delivered within 24h
Last verifiedNovember 22, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Related Opportunities in United States

Febuxostat National Contract
Olopatadine HCL 0.1% Ophthalmic Solution
Valsartan
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

See every United States Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Your 14-Day Free Trial

Free 14-day trial · cancel anytime

See who is already competing here →